AI assistant
Sending…
Pluri Inc. — Director's Dealing 2008
Apr 1, 2008
6990_dirs_2008-04-01_117a2711-0208-4281-9a11-34648fceb31d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2007-11-14
Reporting Person: ROSMAN NACHUM (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-11-14 | Stock options(right to buy) | $6.8 | A | 36250 | Acquired | 2017-11-13 | Common stock (36250) | Direct |
Footnotes
F1: The number of options and the exercise price are after the effect of the 1 for 200 reverse split that occurred on November
26, 2007.
F2: The options vest as follows: 25% on the six month anniversary of the date of grant, 4% on the 7 month and each successive
month anniversary to and including the 23rd month anniversary and the balance on the 24 month anniversary.
F3: The option was granted in recognition of services provided by the reporting person.
More from Pluri Inc.
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
Jun 2
Report Publication Announcement
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 23
Report Publication Announcement
2026
Apr 23